Avidity Biosciences Shares Managed Access Program FAQ

January 28, 2026

On January 22, 2026, Avidity Bioscience shared a Managed Access Program (MAP) – Frequently Asked Questions sheet with the Duchenne community to provide clarity and address the most frequently asked questions.

To view this FAQ sheet, please click here.

Experience the magic this summer!

How is the rare disease community accomplishing goals?

Tune in on February 29 to hear from our panel and moderators on how they are accomplishing goals and living life to the fullest!

Your gift helps Jett Foundation provide programming and opportunities, such as Camp Promise, to many families impacted by Duchenne muscular dystrophy each year.

Accessible Vehicle Fund Applications Open